ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 172599 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 172599; 2) Community: the network communities that were significantly associated with the response to NSC 172599; 3) Molecule: the relationships between components within communities and NSC 172599; 4) MDR: the compounds that were significantly associated with the NSC 172599.

NSC Compound Enrichment Correlation
NSC 276382 PEPLEOMYCIN 0.00707875925191925 -0.01669093
NSC 294979 BLEOMYCIN-BAPP 0.00707875925191925 -0.13501314
NSC 295641 Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester 0.00707875925191925 0.22117855
NSC 317908 Null 0.00707875925191925 0.44918238
NSC 324368 3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide 0.00707875925191925 0.19855872
NSC 605756 Null 0.00707875925191925 0.24002035
NSC 626673 Null 0.00707875925191925 0.21021969
NSC 633530 1H-Pyrido[3,4-b]indol-1-one, 2,3,4,9-tetrahydro-2-[4-(4- phenyl-1-piperazinyl)butyl]-9-methyl- 0.00707875925191925 0.23137589
NSC 639504 Cyclopentanone, 2-[(dimethylamino)methyl]-5-octylidene-, hydrochloride 0.00707875925191925 0.28789393
NSC 639512 Cyclopentanone, 2-[(4-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.00707875925191925 0.34872323
Total:177  Current:59    [First] [Prev] [Next] [Last]